Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Identification of Novel Putative Immunogenic Targets and Construction of a Multi-Epitope Vaccine Against Multidrug-Resistant Corynebacterium Jeikeium Using Reverse Vaccinology Approach Publisher Pubmed



Shahbazi S1 ; Sabzi S1, 2 ; Noori Goodarzi N3 ; Fereshteh S2 ; Bolourchi N2 ; Mirzaie B5 ; Badmasti F1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran
  2. 2. Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran
  3. 3. Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran
  5. 5. Department of Medical Microbiology and Virology, School of Medicine, Zanjan University of Medical Science, Iran

Source: Microbial Pathogenesis Published:2022


Abstract

The emergence of multidrug-resistant Corynebacterium jeikeium has limited treatment options and resulted in the inability to treat C. jeikeium infections, especially in immunocompromised patients. To our knowledge, no studies have been conducted to evaluate C. jeikeium antigens for vaccine development. Given the lack of effective treatments against C. jeikeium, this study aimed to identify potential immunogenic targets against C. jeikeium as a nosocomial pathogen using a reverse vaccinology approach. To achieve this goal, we performed several immuninformatics analyses, including antigenicity, allergenicity, PSI-BLAST to the human proteome, physiochemical properties, B-cell and T-cell epitopes, molecular docking, and immunosimulation. In addition, quartile scoring and prevalence assessment were used to select the most abundant immunogenic targets in different C. jeikeium strains. Finally, protein-protein interactions were performed and the multi-epitope vaccine was developed. Five putative immunogenic targets were presented as short-listed proteins in this study, including three enzymatic proteins (WP_011273969.1, WP_041626322.1, and WP_005292204.1), one protein with DUF3235 domain (WP_011273103.1), and one hypothetical protein (WP_005293648.1). Four linear B-cell epitopes of putative immunogenic targets, including WP_011273103.1 (LNSKPTPRNAAAKPKAK), WP_011273969.1 (GEGAQGSAAPADAQATANE), WP_005292204.1 (ASVSAAQKADGIAP), and WP_041626322.1 (YSKKVAEEMGVG) were selected and inserted into the mutant TbpB C-lobe protein. This platform can effectively present multiple epitopes to the immune system. However, experimental in vitro and in vivo analysis is required to confirm the safety, immunoreactivity, and efficacy of these putative immunogenic targets. © 2022 Elsevier Ltd
Experts (# of related papers)
Other Related Docs
23. In Silico Analysis for Determination and Validation of Iron-Regulated Protein From Escherichia Coli, International Journal of Peptide Research and Therapeutics (2019)
24. Designing a Chimeric Vaccine Against Colorectal Cancer, International Journal of Cancer Management (2017)
26. Computer-Assisted Multi-Epitopes T-Cell Subunit Covid-19 Vaccine Design, Biomedical and Biotechnology Research Journal (2021)
37. Design of a Multi-Epitope Vaccine Against Sars-Cov-2 Using Immunoinformatics Approach, International Journal of Biological Macromolecules (2020)